about
Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cellsThe Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and ProgressionVirilization of the female spotted hyena cannot be explained by alterations in the amino acid sequence of the androgen receptor (AR).Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappaB sequence in human MCF7 breast cancer cells.Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cells.Rapid estradiol/ERalpha signaling enhances aromatase enzymatic activity in breast cancer cells.Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cellsInhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.Estrogen receptor (ER)alpha and ER beta are both expressed in human ejaculated spermatozoa: evidence of their direct interaction with phosphatidylinositol-3-OH kinase/Akt pathway.The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells.Therapeutic potential of leptin receptor modulators.In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancerA novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo.Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis.Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination.Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter.Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferationCombined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells.Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines.The multifactorial role of leptin in driving the breast cancer microenvironment.Triiodothyronine decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse Sertoli cell line, TM4.Impact of R264C and R264H polymorphisms in human aromatase function.A Palladium-Catalyzed Carbonylation Approach to Eight-Membered Lactam Derivatives with Antitumor Activity.Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development.Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.Leptin, obesity and breast cancer: progress to understanding the molecular connections.Evidences that estrogen receptor α interferes with adiponectin effects on breast cancer cell growth.T3 enhances thyroid cancer cell proliferation through TRβ1/Oct-1-mediated cyclin D1 activation.Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells.Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation.Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene.Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation.Identification of bioactive constituents of Ziziphus jujube fruit extracts exerting antiproliferative and apoptotic effects in human breast cancer cells.Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation.Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system.Bid as a potential target of apoptotic effects exerted by low doses of PPARγ and RXR ligands in breast cancer cells.Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells.
P50
Q24316364-1E0B51ED-3688-445C-A10A-33F92203597BQ27004212-AAC250E6-6E7F-41A3-BAF2-221BA5809C39Q31109944-57B8DAE5-68B5-4EC8-9D37-4EE1CE5D7370Q33252788-B321F0D3-F4DB-4D1A-BD6B-50BAF10BB1A1Q33614071-4F2148CD-9173-41F3-86AA-A8752A723C84Q33642075-C6A2188D-8DE3-4577-AF7E-A0544D285E06Q34010406-9A7DAE7E-2005-454D-811F-B394598B6D60Q34122589-E2927044-AA54-495B-A125-875B51364601Q34303291-DF4E1A08-E0D1-4937-9CD7-1D6835CB399FQ34458590-E610E633-3064-4BFE-AA83-5085B85CA148Q35134820-0F8888D1-4508-41B7-ABDB-DEBAF579970EQ35168034-FF0529B3-8A50-43CC-8F15-5418A9489FA8Q35571965-98B89C17-7626-4AC0-B680-EFB86EFC73B0Q35745592-E358B282-578F-4A3B-B7BD-F7CB8FEABCE9Q35786199-094410F6-25C6-44F9-90B3-CE37168D6B84Q35794268-D1F28B1E-A917-41C5-B1A5-088464AF381EQ36123897-7C4680DA-1C13-41B2-9F92-C5D675386DC2Q36602170-3118416F-2773-45C5-9909-22A7482AC66AQ37062022-CF3797AD-21E8-4F74-955A-1C4135B7FB45Q37316564-AC8A33F1-680E-461A-88B5-A309E6A57B89Q37690691-331EFF58-5B24-4336-9121-87C3303493ACQ37956115-7043AABD-5A39-491A-A165-F08518ABEA47Q38357687-5BD23C98-897F-470F-ADD4-8B896BE1A844Q38742512-62C8CAD6-6DF9-477A-BEA3-AC28485308E7Q38798602-44DA0DD4-8CBF-4DBC-91AF-C61099998ED2Q38918424-3F9A3552-7022-4815-B44F-B543DF9ADFC3Q38984903-95858D5C-DB7F-489A-8826-304EB6770667Q38999424-F4543C35-7A14-42EC-86CD-AAE497D84900Q39043755-C23A5532-6986-4564-9710-659FDBEF842CQ39080060-C635372C-054F-4B90-BFEC-CEA7ACED4601Q39282469-6AF2A3B3-313E-479F-BAE5-68B505A31628Q39294358-5C4D2DDD-F04F-4A5A-A6BF-446522BE2BF0Q39312236-607D1A84-CC2D-470C-BFE1-F03F4CDAE7BBQ39321742-EB2C815C-2BC3-43F7-94CF-A8B970BD70A8Q39402371-A962D6B1-4221-47DF-AA70-B4EAEECB2040Q39418462-FF8A477D-D46D-4525-8967-44AFCA5A746CQ39504547-39F3BEEC-4ABF-4314-BC3F-9208A6C33B63Q39528455-62F0BDD0-949D-46B8-A68D-366ADD6B0EE9Q39977536-DC6EC1F5-98EA-40C0-8645-9D1EB4A138CAQ40585585-784D2E83-F6A2-4C88-A493-E6E18F24D89E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stefania Catalano
@ast
Stefania Catalano
@en
Stefania Catalano
@es
Stefania Catalano
@nl
type
label
Stefania Catalano
@ast
Stefania Catalano
@en
Stefania Catalano
@es
Stefania Catalano
@nl
prefLabel
Stefania Catalano
@ast
Stefania Catalano
@en
Stefania Catalano
@es
Stefania Catalano
@nl
P106
P1153
7006324334
P21
P31
P496
0000-0002-6352-9628